Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized Controlled Trial

Conaghan, PG orcid.org/0000-0002-3478-5665, Bowes, MA, Kingsbury, SR orcid.org/0000-0002-9917-1269 et al. (9 more authors) (2020) Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized Controlled Trial. Annals of Internal Medicine, 172 (2). pp. 86-95. ISSN 0003-4819

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 American College of Physicians. All Rights Reserved. This is an author produced version of an article published in Annals of Internal Medicine. Reproduced with permission from the publisher.
Dates:
  • Accepted: 29 October 2019
  • Published (online): 31 December 2019
  • Published: 21 January 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Nov 2019 13:42
Last Modified: 26 Aug 2020 11:13
Status: Published
Publisher: American College of Physicians
Identification Number: https://doi.org/10.7326/M19-0675

Export

Statistics